cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2020-35-1-28-37cardiotomsk-910Research ArticleКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯCLINICAL STUDIESОсобенности динамики артериального давления и провоспалительных маркеров после ренальной денервации у пациентов с резистентной артериальной гипертензией и различным течением коронарного атеросклерозаBlood pressure and proinflammatory marker dynamics after renal denervation in patients with resistant hypertension and various severity of coronary atherosclerosishttps://orcid.org/0000-0001-6995-9875ЗюбановаИ. В.ZyubanovaI. V.

111a, Kievskaya str., Tomsk, 634012, Russian Federation

zyubanovaiv@mail.ruhttps://orcid.org/0000-0002-2238-4573МордовинВ. Ф.MordovinV. F.

Dr. Sci. (Med.), Head of the Department of Hypertension

111a, Kievskaya str., Tomsk, 634012, Russian Federation

 

mordovin@cardio-tomsk.ruhttps://orcid.org/0000-0002-4008-4021ПекарскийС. Е.PekarskiyS. E.

Dr. Sci. (Med.), Leading Research Scientist, Department of Hypertension

111a, Kievskaya str., Tomsk, 634012, Russian Federation

pekarski@cardio-tomsk.ruhttps://orcid.org/0000-0001-5898-0361РиппТ. М.RippT. M.

д-р мед. наук, ведущий научный сотрудник, отделение артериальных гипертоний

E-mail: rripp@mail.ru 634012, Российская Федерация, Томск, ул. Киевская, 111а

Dr. Sci. (Med.), Leading Research Scientist, Department of Hypertension

111a, Kievskaya str., Tomsk, 634012, Russian Federation

ripp@cardio-tomsk.ruhttps://orcid.org/0000-0002-5638-3034ФальковскаяА. Ю.FalkovskayaA. Yu.

Cand. Sci. (Med.), Senior Research Scientist, Department of Hypertension

111a, Kievskaya str., Tomsk, 634012, Russian Federation

alla@cardio-tomsk.ruhttps://orcid.org/0000-0003-4066-869XЛичикакиВ. А.LichikakiV. A.

Cand. Sci. (Med.), Research Scientist, Department of Hypertension

111a, Kievskaya str., Tomsk, 634012, Russian Federation

manankovalera@mail.ruhttps://orcid.org/0000-0002-0988-3642СитковаЕ. С.SitkovaE. S.

Cand. Sci. (Med.), Research Scientist, Department of Hypertension

111a, Kievskaya str., Tomsk, 634012, Russian Federation

chekruzhova@mail.ruhttps://orcid.org/0000-0001-8798-1531БухароваЭ. К.BukharovaE. K.

111a, Kievskaya str., Tomsk, 634012, Russian Federation

elmira@cardio-tomsk.ruhttps://orcid.org/0000-0002-3147-3025ГусаковаА. М.GusakovaA. M.

Cand. Sci. (Pharm.), Research Scientist, Department of Functional and Laboratory Diagnostics

111a, Kievskaya str., Tomsk, 634012, Russian Federation

mag_a@mail.ruhttps://orcid.org/0000-0002-8163-1618БаевА. Е.BaevA. E.

Cand. Sci. (Med.), Head of Department of Invasive Cardiology

111a, Kievskaya str., Tomsk, 634012, Russian Federation

 

stent111@mail.ruНаучно-исследовательский институт кардиологии,Томский национальный исследовательский медицинский центр Российской академии наукРоссияCardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesRussian Federation2020090420203512837Copyright © Зюбанова И.В., Мордовин В.Ф., Пекарский С.Е., Рипп Т.М., Фальковская А.Ю., Личикаки В.А., Ситкова Е.С., Бухарова Э.К., Гусакова А.М., Баев А.Е., 20202020Зюбанова И.В., Мордовин В.Ф., Пекарский С.Е., Рипп Т.М., Фальковская А.Ю., Личикаки В.А., Ситкова Е.С., Бухарова Э.К., Гусакова А.М., Баев А.Е.Zyubanova I.V., Mordovin V.F., Pekarskiy S.E., Ripp T.M., Falkovskaya A.Y., Lichikaki V.A., Sitkova E.S., Bukharova E.K., Gusakova A.M., Baev A.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/910резистентная артериальная гипертензияренальная денервациякоронарный атеросклерозвысокочувствительный С-реактивный белокфактор некроза опухоли альфаresistant hypertensionrenal denervationcoronary atherosclerosishigh-sensitivity C-reactive proteintumor necrosis factor-alphaReferencesMacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J. et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765–774.MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J. et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765–774.Virdis A., Dell’Agnello U., Taddei S. Impact of inflammation on vascular disease in hypertension. Maturitas. 2014;78(3):179–183. DOI: 10.1016/j.maturitas.2014.04.012.Virdis A., Dell’Agnello U., Taddei S. Impact of inflammation on vascular disease in hypertension. Maturitas. 2014;78(3):179–183. DOI: 10.1016/j.maturitas.2014.04.012.Василец Л.М., Григориади Н.Е., Гордийчук Р.Н., Карпунина Н.С., Щербенев В.М. Прогностическая значимость факторов системного воспаления у больных с ишемической болезнью сердца. Сибирский медицинский журнал (Иркутск). 2013;116(1):50–52.Vasilec L.M., Grigoriadi N.E., Gordijchuk R.N., Karpunina N.S., Shcherbenev V.M. The prognostic significance of systemic inflammation factors in patients with coronary heart disease. Siberian Medical Journal (Irkutsk). 2013;116(1):50–52 (In Russ.).Зюбанова И.В., Мордовин В.Ф., Фальковская А.Ю., Пекарский С.Е. Изменения показателей суточного мониторирования артериального давления под влиянием ренальной денервации в течение 12-месячного наблюдения. Сибирский медицинский журнал. 2015;30(3):41–44. DOI: 10.29001/2073-8552-2015-30-3-41-44.Zyubanova I.V., Mordovin V.F., Falkovskaja A.Y., Pekarsky S.E. Changes in ambulatory blood pressure monitoring data after renal denervation: 12-month follow-up. The Siberian Medical Journal. 2015;30(3):41–44 (In Russ.). DOI: 10.29001/2073-8552-2015-30-3-41-44.Рипп Т.М., Мордовин В.Ф., Пекарский С.Е., Рябова Т.Р., Злобина М.В., Семке Г.В. и др. Кардиопротективные возможности денервации почек при лечении резистентной гипертонии, поиск предикторов эффективности. Артериальная гипертензия. 2014;20(6):559–567. DOI: 10.18705/1607-419X-2014-20-6-559-567.Ripp T.M., Mordovin V.F., Pekarskiy S.E., Ryabova T.P., Zlobina M.Z., Semke G.V. et al. Cardioprotective effects of renal denervation in resistant hypertension: efficiency predictors. Arterial Hypertension. 2014;20(6):559–567 (In Russ.). DOI: 10.18705/1607-419X-2014-20-6-559-567.Фальковская А.Ю., Мордовин В.Ф., Пекарский С.Е., Баев А.Е., Семке Г.В., Рипп Т.М. и др. Дополнительные благоприятные эффекты симпатической денервации почек при лечении резистентной артериальной гипертензии у больных сахарным диабетом 2-го типа. Артериальная гипертензия. 2014;20(2):107–112. DOI: 10.18705/1607-419X-2014-20-2-107-112.Falkovskaya A.Y., Mordovin V.F., Pekarskiy S.E., Baev A.E., Semke G.V., Ripp T.M. et al. Transcatheter renal denervation in patients with resistant hypertension and type 2 diabetes mellitus has beneficial effects beyond blood pressure reduction. Arterial Hypertension. 2014;20(2):107–112 (In Russ.). DOI: 10.18705/1607-419X-2014-20-2-107-112.Mahfoud F., Böhm M., Schmieder R., Narkiewicz K., Ewen S., Ruilope L. et al. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry. European Heart Journal. 2019;21:ehz118. DOI: 10.1093/eurheartj/ehz118.Mahfoud F., Böhm M., Schmieder R., Narkiewicz K., Ewen S., Ruilope L. et al. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry. European Heart Journal. 2019;21:ehz118. DOI: 10.1093/eurheartj/ehz118.Atti V., Turagam M.K., Garg J., Lakkireddy D. Renal sympathetic denervation improves clinical outcomes in patients undergoing catheter ablation for atrial fibrillation and history of hypertension: A meta-analysis. J. Cardiovasc. Electrophysiol. 2019;30(5):702–708. DOI: 10.1111/jce.13868.Atti V., Turagam M.K., Garg J., Lakkireddy D. Renal sympathetic denervation improves clinical outcomes in patients undergoing catheter ablation for atrial fibrillation and history of hypertension: A meta-analysis. J. Cardiovasc. Electrophysiol. 2019;30(5):702–708. DOI: 10.1111/jce.13868.Gao J.Q., Yang W., Liu Z. Percutaneous renal artery denervation in patients with chronic systolic heart failure: a randomized controlled trial. Cardiol. J. 2018;3. DOI: 10.5603/CJ.a2018.0028.Gao J.Q., Yang W., Liu Z. Percutaneous renal artery denervation in patients with chronic systolic heart failure: a randomized controlled trial. Cardiol. J. 2018;3. DOI: 10.5603/CJ.a2018.0028.Dörr O., Liebetrau C., Möllmann H., Mahfoud F., Ewen S., Gaede L. et al. Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension. Clin. Res. Cardiol. 2015;104(2):175–184. DOI: 10.1007/s00392-014-0773-4.Dörr O., Liebetrau C., Möllmann H., Mahfoud F., Ewen S., Gaede L. et al. Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension. Clin. Res. Cardiol. 2015;104(2):175–184. DOI: 10.1007/s00392-014-0773-4.Kablak-Ziembicka A., Przewlocki T., Sokołowski A., Tracz W., Podolec P. Carotid intima-media thickness, hs-CRP and TNF-α are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis. 2011;214(1):185–190. DOI: 10.1016/j.atherosclerosis.2010.10.017.Kablak-Ziembicka A., Przewlocki T., Sokołowski A., Tracz W., Podolec P. Carotid intima-media thickness, hs-CRP and TNF-α are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis. 2011;214(1):185–190. DOI: 10.1016/j.atherosclerosis.2010.10.017.Kotchen T.A. Hypertensive vascular diseases. In: Kasper D., Fauci A., Hauser S., Longo D., Jameson J., Loscalzo J., editors. Harrison’s principles of internal medicine. New York: McGraw-Hill; 2015:1611–1626.Kotchen T.A. Hypertensive vascular diseases. In: Kasper D., Fauci A., Hauser S., Longo D., Jameson J., Loscalzo J., editors. Harrison’s principles of internal medicine. New York: McGraw-Hill; 2015:1611–1626.Völz S., Svedlund S., Andersson B., Li-Ming G., Rundqvist B. Coronary flow reserve in patients with resistant hypertension. Clin. Res. Cardiol. 2017;106(2):151–157. DOI: 10.1007/s00392-016-1043-4.Völz S., Svedlund S., Andersson B., Li-Ming G., Rundqvist B. Coronary flow reserve in patients with resistant hypertension. Clin. Res. Cardiol. 2017;106(2):151–157. DOI: 10.1007/s00392-016-1043-4.Gonçalves I., Edsfeldt A., Colhoun H.M. , Shore A.C., Palombo C., Natali A. et al. SUMMIT consortium. Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes. BMC Cardiovasc. Disord. 2016;171. DOI: 10.1186/s12872-016-0346-8.Gonçalves I., Edsfeldt A., Colhoun H.M. , Shore A.C., Palombo C., Natali A. et al. SUMMIT consortium. Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes. BMC Cardiovasc. Disord. 2016;171. DOI: 10.1186/s12872-016-0346-8.Zhu M., Lin J., Wang C., Yang M., Lv H., Yang M. et al. The relationship among angiotensinogen genes polymorphisms and hs-CRP and coronary artery disease. J. Clin. Lab. Anal. 2019;33(5):e22881. DOI: 10.1002/jcla.22881.Zhu M., Lin J., Wang C., Yang M., Lv H., Yang M. et al. The relationship among angiotensinogen genes polymorphisms and hs-CRP and coronary artery disease. J. Clin. Lab. Anal. 2019;33(5):e22881. DOI: 10.1002/jcla.22881.Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999;340(2):115–126.Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999;340(2):115–126.Yu X., Yang Z., Yu M. Correlation of tumor necrosis factor alpha and interleukin 6 with hypertensive renal damage. Ren. Fail. 2010;32(4):475–479. DOI: 10.3109/08860221003664280.Yu X., Yang Z., Yu M. Correlation of tumor necrosis factor alpha and interleukin 6 with hypertensive renal damage. Ren. Fail. 2010;32(4):475–479. DOI: 10.3109/08860221003664280.Fon Tacer K., Kuzman D., Seliskar M., Pompon D., Rozman D. TNF-alpha interferes with lipid homeostasis and activates acute and proatherogenic processes. Physiol. Genomics. 2007;31(2):216–227. DOI: 10.1152/physiolgenomics.00264.2006.Fon Tacer K., Kuzman D., Seliskar M., Pompon D., Rozman D. TNF-alpha interferes with lipid homeostasis and activates acute and proatherogenic processes. Physiol. Genomics. 2007;31(2):216–227. DOI: 10.1152/physiolgenomics.00264.2006.Tajfard M., Tavakoly Sany S.B., Avan A., Latiff L.A., Rahimi H.R., Moohebati M. et al. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors. J. Cell Physiol. 2019;234(7):10289–10299. DOI: 10.1002/jcp.27945.Tajfard M., Tavakoly Sany S.B., Avan A., Latiff L.A., Rahimi H.R., Moohebati M. et al. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors. J. Cell Physiol. 2019;234(7):10289–10299. DOI: 10.1002/jcp.27945.Tan Z., Li L., Ma Y., Geng X. Clinical significance of cys-C and hs-CRP in coronary heart disease patients undergoing percutaneous coronary intervention. Braz. J. Cardiovasc. Surg. 2019;34(1):17–21. DOI: 10.21470/1678-9741-2018-0171.Tan Z., Li L., Ma Y., Geng X. Clinical significance of cys-C and hs-CRP in coronary heart disease patients undergoing percutaneous coronary intervention. Braz. J. Cardiovasc. Surg. 2019;34(1):17–21. DOI: 10.21470/1678-9741-2018-0171.Yao W., Wang N., Qian J., Bai L., Zheng X., Hou G. et al. Renal sympathetic denervation improves myocardial apoptosis in rats with isoproterenol-induced heart failure by downregulation of tumor necrosis factor-α and nuclear factor-κB. Exp. Ther. Med. 2017;14(5):4104–4110. DOI: 10.3892/etm.2017.5066.Yao W., Wang N., Qian J., Bai L., Zheng X., Hou G. et al. Renal sympathetic denervation improves myocardial apoptosis in rats with isoproterenol-induced heart failure by downregulation of tumor necrosis factor-α and nuclear factor-κB. Exp. Ther. Med. 2017;14(5):4104–4110. DOI: 10.3892/etm.2017.5066.Liu Q., Zhang Q., Wang K., Wang S., Lu D., Li Z. et al. Renal denervation findings on cardiac and renal fibrosis in rats with isoproterenol induced cardiomyopathy. Sci. Rep. 2015;5:18582. DOI: 10.1038/srep18582.Liu Q., Zhang Q., Wang K., Wang S., Lu D., Li Z. et al. Renal denervation findings on cardiac and renal fibrosis in rats with isoproterenol induced cardiomyopathy. Sci. Rep. 2015;5:18582. DOI: 10.1038/srep18582.Фальковская А.Ю., Мордовин В.Ф., Пекарский С.Е., Баев А.Е., Семке Г.В., Рипп Т.М. и др. Динамика состояния углеводного обмена после ренальной денервации у больных резистентной артериальной гипертонией в сочетании с сахарным диабетом 2-го типа. Бюллетень сибирской медицины. 2015;14(5):82–90. DOI: 10.20538/1682-0363-2015-5-82-90.Falkovskaya A.Y., Mordovin V.F., Pekarsky S.Y., Bayev A.Y., Semke G.V., Ripp T.M. et al. Dynamics of glycemic control after renal denervation in patients with resistant hypertension and type 2 diabetes mellitus. Bulletin of Siberian Medicine. 2015;14(5):82–90 (In Russ.). DOI: 10.20538/1682-0363-2015-5-82-90.Barcelos A.L.V., de Oliveira E.A., Haute G.V., Costa B.P., Pedrazza L., Donadio M.V.F. et al. Association of IL-10 to coronary disease severity in patients with metabolic syndrome. Clin. Chim. Acta. 2019;495:394–398. DOI: 10.1016/j.cca.2019.05.006.Barcelos A.L.V., de Oliveira E.A., Haute G.V., Costa B.P., Pedrazza L., Donadio M.V.F. et al. Association of IL-10 to coronary disease severity in patients with metabolic syndrome. Clin. Chim. Acta. 2019;495:394–398. DOI: 10.1016/j.cca.2019.05.006.

The authors declare that there are no conflicts of interest present.